Circulating biomarkers and cardiac function over 3 years after chemotherapy with anthracyclines: the ICOS‐ONE trial

AIMS: A multicentre trial, ICOS‐ONE, showed increases above the upper limit of normality of cardiac troponin (cTn) in 27% of patients within 12 months after the end of cancer chemotherapy (CT) with anthracyclines, whether cardiac protection with enalapril was started at study entry in all (preventio...

Descripción completa

Detalles Bibliográficos
Autores principales: Meessen, Jennifer M.T.A., Cardinale, Daniela, Ciceri, Fabio, Sandri, Maria Teresa, Civelli, Maurizio, Bottazzi, Barbara, Cucchi, GianFranco, Menatti, Elisabetta, Mangiavacchi, Maurizio, Condorelli, Gianluigi, Barbieri, Enrico, Gori, Stefania, Colombo, Alessandro, Curigliano, Giuseppe, Salvatici, Michela, Pastori, Paolo, Ghisoni, Francesco, Bianchi, Alessandra, Falci, Cristina, Cortesi, Pietro, Farolfi, Alberto, Monopoli, Anna, Milandri, Carlo, Bregni, Marco, Malossi, Alessandra, Nassiacos, Daniele, Verusio, Claudio, Staszewsky, Lidia, Leone, Roberto, Novelli, Deborah, Balconi, Giovanna, Nicolis, Enrico B., Franzosi, Maria Grazia, Masson, Serge, Garlanda, Cecilia, Mantovani, Alberto, Cipolla, Carlo M., Latini, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373944/
https://www.ncbi.nlm.nih.gov/pubmed/32358917
http://dx.doi.org/10.1002/ehf2.12695

Ejemplares similares

Ejemplares similares